Primary completion date: Sep 2023 to Sep 2034
Completion date: Sep 2024 to Sep 2034
Study Statusv16
Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00204035 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trialPrimary completion date: Sep 2023 to Sep 2034
Completion date: Sep 2024 to Sep 2034
Study Statusv16
Primary completion date: Sep 2017 to Sep 2023
Trial status: Recruiting to Active, Not Recruiting; Completion date: Sep 2020 to Sep 2024; Site details revised
Study Status, Contacts/Locationsv15
2 amendments
2 re-verifications since 2017-01-24, no change to tracked fields
v13-v14
Primary completion date: Sep 2015 to Sep 2017
Study Statusv12
Enrollment target: 40 to 400
Study Status, Study Designv11
2 amendments
2 re-verifications since 2010-08-25, no change to tracked fields
v9-v10
Study Status, Outcome Measures
v8
Primary completion date: Sep 2015
Completion date: Sep 2020; Study description expanded, about 154 words
Study Status, Study Descriptionv7
Eligibility criteria revised
Study Status, Sponsor/Collaborators, Study Description, Study Design, Arms and Interventions, Eligibilityv6
4 amendments
4 re-verifications since 2006-03-10, no change to tracked fields
v2-v5
Study First Submitted
| NCT Number | NCT00204035 |
| Lead Sponsor | University of Chicago |
| Conditions | Healthy |
| Enrollment | 400 participants |
| Start Date | |
| Primary Completion | (estimated) |
| Study Completion | (estimated) |
| Updated on ClinicalTrials.gov |